• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
α2-containing GABA(A) receptors: a target for the development of novel treatment strategies for CNS disorders.含 α2 亚基的 GABA(A) 受体:开发治疗中枢神经系统疾病新疗法的靶点。
Pharmacol Ther. 2012 Nov;136(2):142-52. doi: 10.1016/j.pharmthera.2012.08.006. Epub 2012 Aug 18.
2
A Pharmacogenetic 'Restriction-of-Function' Approach Reveals Evidence for Anxiolytic-Like Actions Mediated by α5-Containing GABAA Receptors in Mice.一种药物遗传学“功能限制”方法揭示了含α5的GABAA受体介导的小鼠抗焦虑样作用的证据。
Neuropsychopharmacology. 2016 Sep;41(10):2492-501. doi: 10.1038/npp.2016.49. Epub 2016 Apr 12.
3
Human pharmacology of positive GABA-A subtype-selective receptor modulators for the treatment of anxiety.治疗焦虑的正 GABA-A 亚型选择性受体调节剂的人体药理学。
Acta Pharmacol Sin. 2019 May;40(5):571-582. doi: 10.1038/s41401-018-0185-5. Epub 2018 Dec 5.
4
HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain.HZ166,一种新型 GABAA 受体亚型选择性苯二氮䓬结合位点配体,在炎症性和神经性疼痛的小鼠模型中具有抗痛觉过敏作用。
Neuropharmacology. 2011 Mar;60(4):626-32. doi: 10.1016/j.neuropharm.2010.11.026. Epub 2010 Dec 8.
5
The effects of TPA023, a GABAAα2,3 subtype-selective partial agonist, on essential tremor in comparison to alcohol.TPA023(一种 GABAAα2,3 亚型选择性部分激动剂)对特发性震颤的作用与酒精的比较。
J Psychopharmacol. 2012 Feb;26(2):282-91. doi: 10.1177/0269881111415731. Epub 2011 Sep 2.
6
GABAA receptor subtype-selective modulators. II. α5-selective inverse agonists for cognition enhancement.GABAA 受体亚型选择性调节剂。二、用于认知增强的 α5 选择性反向激动剂。
Curr Top Med Chem. 2011;11(9):1203-14. doi: 10.2174/156802611795371314.
7
Targeted deletion of the GABRA2 gene encoding alpha2-subunits of GABA(A) receptors facilitates performance of a conditioned emotional response, and abolishes anxiolytic effects of benzodiazepines and barbiturates.对编码γ-氨基丁酸A(GABA(A))受体α2亚基的GABRA2基因进行靶向缺失,可促进条件性情绪反应的表现,并消除苯二氮䓬类药物和巴比妥类药物的抗焦虑作用。
Pharmacol Biochem Behav. 2008 Jul;90(1):1-8. doi: 10.1016/j.pbb.2008.01.015. Epub 2008 Jan 31.
8
GABAA receptor subtype-selective modulators. I. α2/α3-selective agonists as non-sedating anxiolytics.GABAA 受体亚型选择性调节剂。I. α2/α3 选择性激动剂作为非镇静性抗焦虑药。
Curr Top Med Chem. 2011;11(9):1176-202. doi: 10.2174/156802611795371350.
9
Alpha1- and alpha2-containing GABAA receptor modulation is not necessary for benzodiazepine-induced hyperphagia.含有α1和α2的GABAA受体调节对于苯二氮䓬类药物诱导的摄食过多并非必要。
Appetite. 2009 Jun;52(3):675-683. doi: 10.1016/j.appet.2009.03.006. Epub 2009 Mar 20.
10
A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia.一项关于 MK-0777 治疗精神分裂症患者认知障碍的随机临床试验。
Biol Psychiatry. 2011 Mar 1;69(5):442-9. doi: 10.1016/j.biopsych.2010.09.052. Epub 2010 Dec 8.

引用本文的文献

1
Resolving native GABA receptor structures from the human brain.解析来自人类大脑的天然GABA受体结构。
Nature. 2025 Feb;638(8050):562-568. doi: 10.1038/s41586-024-08454-1. Epub 2025 Jan 22.
2
Atp1a2 and Kcnj9 Are Candidate Genes Underlying Sensitivity to Oxycodone-Induced Locomotor Activation and Withdrawal-Induced Anxiety-Like Behaviors in C57BL/6 Substrains.Atp1a2和Kcnj9是C57BL/6亚系中对羟考酮诱导的运动激活和戒断诱导的焦虑样行为敏感的候选基因。
Genes Brain Behav. 2025 Feb;24(1):e70009. doi: 10.1111/gbb.70009.
3
Multi-Target Mechanisms of Si-Ni-San on Anxious Insomnia: An Example of Network-pharmacology and Molecular Docking Analysis.四逆散治疗焦虑性失眠的多靶点作用机制:基于网络药理学和分子对接分析的实例
Curr Med Chem. 2024 Oct 9. doi: 10.2174/0109298673299665240924090617.
4
Characterization of the zebrafish gabra1 germline loss of function allele confirms a function for Gabra1 in motility and nervous system development.斑马鱼 gabra1 种系功能丧失突变等位基因的特征鉴定证实了 Gabra1 在运动和神经系统发育中的功能。
Differentiation. 2024 Jul-Aug;138:100790. doi: 10.1016/j.diff.2024.100790. Epub 2024 Jun 15.
5
and are candidate genes underlying sensitivity to oxycodone-induced locomotor activation and withdrawal-induced anxiety-like behaviors in C57BL/6 substrains.并且 是C57BL/6亚系中对羟考酮诱导的运动激活和戒断诱导的焦虑样行为敏感的候选基因。
bioRxiv. 2024 Sep 9:2024.04.16.589731. doi: 10.1101/2024.04.16.589731.
6
Advances in Therapeutics to Alleviate Cognitive Decline and Neuropsychiatric Symptoms of Alzheimer's Disease.治疗阿尔茨海默病认知衰退和神经精神症状的新进展。
Int J Mol Sci. 2024 May 9;25(10):5169. doi: 10.3390/ijms25105169.
7
Antinociceptive Effects of 2/3-Subtype-Selective GABA Receptor Positive Allosteric Modulators KRM-II-81 and NS16085 in Male Rats: Behavioral Specificity.2/3 型 GABA 受体正变构调节剂 KRM-II-81 和 NS16085 在雄性大鼠中的抗伤害作用:行为特异性。
J Pharmacol Exp Ther. 2024 Nov 19;391(3):389-398. doi: 10.1124/jpet.123.002070.
8
GABA system as the cause and effect in early development.GABA 系统作为早期发育的因果关系。
Neurosci Biobehav Rev. 2024 Jun;161:105651. doi: 10.1016/j.neubiorev.2024.105651. Epub 2024 Apr 4.
9
Schisandrin B, a dual positive allosteric modulator of GABA and glycine receptors, alleviates seizures in multiple mouse models.五味子丙素是一种 GABA 和甘氨酸受体的双重正变构调节剂,可缓解多种小鼠模型的癫痫发作。
Acta Pharmacol Sin. 2024 Mar;45(3):465-479. doi: 10.1038/s41401-023-01195-3. Epub 2023 Nov 28.
10
Genetics of sleep medication purchases suggests causality from sleep problems to psychiatric traits.睡眠药物购买的遗传学研究提示了睡眠问题到精神特质的因果关系。
Sleep. 2024 Feb 8;47(2). doi: 10.1093/sleep/zsad279.

本文引用的文献

1
Differential roles of GABA(A) receptor subtypes in benzodiazepine-induced enhancement of brain-stimulation reward.GABA(A) 受体亚型在苯二氮䓬类药物增强脑刺激奖赏中的差异作用。
Neuropsychopharmacology. 2012 Oct;37(11):2531-40. doi: 10.1038/npp.2012.115. Epub 2012 Jul 4.
2
Loss of functional GABA(A) receptors in the Alzheimer diseased brain.阿尔茨海默病患者大脑中功能性 GABA(A) 受体的丧失。
Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):10071-6. doi: 10.1073/pnas.1204606109. Epub 2012 Jun 12.
3
Benzodiazepine-induced anxiolysis and reduction of conditioned fear are mediated by distinct GABAA receptor subtypes in mice.苯二氮䓬类药物诱导的焦虑缓解和条件性恐惧的减少是由小鼠中不同的 GABA A 受体亚型介导的。
Neuropharmacology. 2012 Aug;63(2):250-8. doi: 10.1016/j.neuropharm.2012.03.001. Epub 2012 Mar 21.
4
Altered cortical GABA neurotransmission in schizophrenia: insights into novel therapeutic strategies.精神分裂症中皮质 GABA 神经递质传递的改变:对新型治疗策略的深入了解。
Curr Pharm Biotechnol. 2012 Jun;13(8):1557-62. doi: 10.2174/138920112800784925.
5
The GABA system in anxiety and depression and its therapeutic potential.焦虑和抑郁中的 GABA 系统及其治疗潜力。
Neuropharmacology. 2012 Jan;62(1):42-53. doi: 10.1016/j.neuropharm.2011.08.040. Epub 2011 Sep 1.
6
Distinct mechanisms regulate GABAA receptor and gephyrin clustering at perisomatic and axo-axonic synapses on CA1 pyramidal cells.不同的机制调节 CA1 锥体神经元胞体和轴突-轴突突触处 GABA A 受体和神经胶质原纤维酸性蛋白的聚集。
J Physiol. 2011 Oct 15;589(Pt 20):4959-80. doi: 10.1113/jphysiol.2011.216028. Epub 2011 Aug 8.
7
Anxiety and depression: mouse genetics and pharmacological approaches to the role of GABA(A) receptor subtypes.焦虑和抑郁:GABA(A) 受体亚型在小鼠遗传学和药理学方法中的作用。
Neuropharmacology. 2012 Jan;62(1):54-62. doi: 10.1016/j.neuropharm.2011.07.026. Epub 2011 Jul 27.
8
Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes.超越经典苯二氮䓬类药物:GABAA 受体亚型的新治疗潜力。
Nat Rev Drug Discov. 2011 Jul 29;10(9):685-97. doi: 10.1038/nrd3502.
9
Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis.神经甾体和 GABA-A 受体在阿尔茨海默病、帕金森病和多发性硬化症中的改变。
Neuroscience. 2011 Sep 15;191:6-21. doi: 10.1016/j.neuroscience.2011.04.010. Epub 2011 Apr 15.
10
Impulsiveness and insula activation during reward anticipation are associated with genetic variants in GABRA2 in a family sample enriched for alcoholism.冲动和奖励预期期间的岛叶激活与 GABRA2 中的遗传变异有关,该基因在富含酒精中毒的家族样本中。
Mol Psychiatry. 2012 May;17(5):511-9. doi: 10.1038/mp.2011.33. Epub 2011 Apr 12.

含 α2 亚基的 GABA(A) 受体:开发治疗中枢神经系统疾病新疗法的靶点。

α2-containing GABA(A) receptors: a target for the development of novel treatment strategies for CNS disorders.

机构信息

Laboratory of Genetic Neuropharmacology, McLean Hospital, Belmont, MA 02478, USA.

出版信息

Pharmacol Ther. 2012 Nov;136(2):142-52. doi: 10.1016/j.pharmthera.2012.08.006. Epub 2012 Aug 18.

DOI:10.1016/j.pharmthera.2012.08.006
PMID:22921455
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3478960/
Abstract

GABA(A) receptors have important physiological functions, as revealed by pharmacological studies and experiments involving gene-targeted mouse models, and are the target of widely used drugs such as the benzodiazepines. In this review, we are summarizing current knowledge about the function of α2-containing GABA(A) receptors, a receptor subtype representing approximately 15-20% of all GABA(A) receptors. This receptor subtype mediates anxiolytic-like, reward-enhancing, and antihyperalgesic actions of diazepam, and has antidepressant-like properties. Secondary insufficiency of α2-containing GABA(A) receptors has been postulated to play a role in the pathogenesis of schizophrenia, and may be involved in cognitive impairment in other disorders. Moreover, polymorphisms in the GABRA2 gene encoding the GABA(A) receptor α2 subunit have been found to be linked to chronic alcohol dependence and to polydrug abuse. Thus, α2-containing GABA(A) receptors are involved in the regulation and/or modulation of emotional behaviors and of chronic pain, and appear to be a valid target for novel therapeutic approaches for the treatment of anxiety, depression, schizophrenia and chronic pain.

摘要

GABA(A) 受体具有重要的生理功能,这一点已被药理学研究和基因靶向小鼠模型实验所揭示,并且是广泛使用的药物(如苯二氮䓬类药物)的作用靶点。在这篇综述中,我们总结了目前关于含 α2 的 GABA(A) 受体(约占所有 GABA(A) 受体的 15-20%)功能的知识。这种受体亚型介导地西泮的抗焦虑样、增强奖赏和抗痛觉过敏作用,并且具有抗抑郁样特性。含 α2 的 GABA(A) 受体的二级功能不足被认为在精神分裂症的发病机制中起作用,并且可能与其他疾病的认知障碍有关。此外,编码 GABA(A) 受体 α2 亚基的 GABRA2 基因的多态性已被发现与慢性酒精依赖和多药物滥用有关。因此,含 α2 的 GABA(A) 受体参与情绪行为和慢性疼痛的调节和/或调制,并且似乎是治疗焦虑症、抑郁症、精神分裂症和慢性疼痛的新型治疗方法的有效靶点。